# Clinical Trial for Measles - Rubella Combined Vaccine (MRVAC) Produced by POLYVAC (Phase III)

> **NCT03713359** · PHASE3 · COMPLETED · sponsor: **Center for Research and Production of Vaccines and Biologicals, Vietnam** · enrollment: 756 (actual)

## Conditions studied

- Signs and Symptoms

## Interventions

- **BIOLOGICAL:** Trial arm (MRVAC)
- **BIOLOGICAL:** Control arm

## Key facts

- **NCT ID:** NCT03713359
- **Lead sponsor:** Center for Research and Production of Vaccines and Biologicals, Vietnam
- **Sponsor class:** OTHER_GOV
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-04
- **Primary completion:** 2016-07
- **Final completion:** 2016-11
- **Target enrollment:** 756 (ACTUAL)
- **Last updated:** 2018-10-19

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03713359

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03713359, "Clinical Trial for Measles - Rubella Combined Vaccine (MRVAC) Produced by POLYVAC (Phase III)". Retrieved via AI Analytics 2026-07-02 from https://api.ai-analytics.org/clinical/NCT03713359. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*